Novo Nordisk had not been able to manufacture enough Wegovy to meet demands, leaving the drug in short supply throughout much of 2023 and 2024
Identifying Suitable Candidates for Semaglutide Potential candidates for a semaglutide weight loss program should ideally have a BMI of 30 or above, or 27 with conditions such as high blood pressure, type 2 diabetes, or high cholesterol
The combined activity of GLP-1 and GIP in Mounjaro offers a broader approach to regulating blood sugar levels and appetite compared to GLP-1 alone
However, because weight loss can change your thyroid hormone requirements, it is essential to monitor your levels closely with your GP, as your dose of levothyroxine may need to be adjusted over time
Patients should not assume these products are safe, legal, accurately dosed, sterile, or appropriate for human use